(Q40385051)

20 September 2017

title

Enhanced maturation and functional capacity of dendritic cells induced by mannosylated L2 domain of ErbB2 receptor (English)

1 reference

20 September 2017

Zhong G

1

1 reference

20 September 2017

Wang J

2

1 reference

20 September 2017

Xu M

3

1 reference

20 September 2017

Xie Z

4

1 reference

20 September 2017

Yu M

5

1 reference

20 September 2017

Wang J

6

1 reference

20 September 2017

Zhou T

7

1 reference

20 September 2017

Gong W

8

1 reference

20 September 2017

Sun Y

9

1 reference

20 September 2017

Hu M

10

1 reference

20 September 2017

Zhang X

11

1 reference

20 September 2017

Shen B

12

1 reference

20 September 2017

Guo N

13

1 reference

20 September 2017

publication date

1 August 2005

1 reference

Scandinavian Journal of Immunology

20 September 2017

published in

1 reference

20 September 2017

volume

62

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

108-116

1 reference

Dendritic cells and the control of immunity

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

The mannose receptor is a pattern recognition receptor involved in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Dendritic cells: On the move from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Antitumor vaccination with HER-2-derived recombinant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

Selection and characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01642.X

10.1111/J.1365-3083.2005.01642.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference